This inventor holds 1 USPTO granted patent. Top assignee: The Green Cross Corporation. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Masahiro Funayama: A Pioneer in Virus Inactivation Process
Introduction
Masahiro Funayama, an innovative inventor based in Hirakata, Japan, has made significant contributions to the field of immunology through his groundbreaking patent. With a focus on enhancing the safety and efficacy of immunoglobulin products, his work has opened new avenues for research and development within the medical community.
Latest Patents
Masahiro Funayama holds a noteworthy patent titled "Process for the virus-inactivation of immunoglobulin." This patent describes a method to virus-inactivate virus-contaminated immunoglobulin by heating it in a substantially dry state at temperatures ranging from 30°C to 100°C. This process not only ensures the inactivation of the virus but also maintains the original activity of the immunoglobulin. Furthermore, the addition of glycine, sodium chloride, sodium acetate, polyethylene glycol, albumin, or mannitol enhances the effect, ensuring good solubility and a stable solution of virus-inactivated immunoglobulin.
Career Highlights
Throughout his career, Masahiro Funayama has been associated with The Green Cross Corporation, where he leverages his expertise in immunology and biotechnology. His innovative approach to virus inactivation has made a meaningful impact on the development and safety of therapeutic products that rely on immunoglobulin.
Collaborations
During his tenure at The Green Cross Corporation, Funayama has worked alongside esteemed colleagues, including Yahiro Uemura and Katuhiro Uriyu. Together, they have contributed to advancing research and development initiatives that focus on enhancing the safety and quality of therapeutic proteins.
Conclusion
Masahiro Funayama's inventive spirit and dedication to scientific advancement have established him as a leading figure in the realm of immunology. His work not only showcases his prowess as an inventor but also highlights the importance of innovation in making medical treatments safer for patients. As advancements continue in this field, Funayama's contributions will likely serve as a foundation for future developments in virus inactivation technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile